Publication | Closed Access

Melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells

Estrogen Receptor TransactivationBreast OncologyMedicineHormonal ReceptorBreast Cancer CellsBreast CancerCamp LevelsEndocrinologyPharmacologyCell BiologyMelatoninCancer ResearchEndocrine-related Cancer